MIRLET7F2

gene
On this page

Also known as hsa-let-7f-2

Summary

MIRLET7F2 (microRNA let-7f-2, HGNC:31484) is a microRNA gene on chromosome Xp11.22.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 406889 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31484
Approved symbolMIRLET7F2
NamemicroRNA let-7f-2
LocationXp11.22
Locus typeRNA, micro
StatusApproved
Aliaseshsa-let-7f-2
Ensembl geneENSG00000208012
Ensembl biotypemiRNA
OMIM300721
Entrez406889
RNAcentralURS000075D19A — miRNA, 83 nt, 92 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000385277

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000385277 — 1 exons

ExonStartEnd
ENSE000015002835355719253557274

Expression profiles

Bgee: expression breadth broad, 30 present calls, max score 82.69.

Top tissues by expression

30 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
muscle of legUBERON:000138382.69gold quality
heartUBERON:000094882.39gold quality
bloodUBERON:000017879.17gold quality
stomachUBERON:000094574.94gold quality
lungUBERON:000204872.49gold quality
endometriumUBERON:000129571.23gold quality
intestineUBERON:000016070.47gold quality
right lobe of liverUBERON:000111470.11gold quality
esophagogastric junction muscularis propriaUBERON:003584167.32gold quality
upper lobe of left lungUBERON:000895267.31gold quality
body of stomachUBERON:000116166.98gold quality
left adrenal glandUBERON:000123466.89gold quality
right hemisphere of cerebellumUBERON:001489066.89gold quality
omental fat padUBERON:001041466.63gold quality
ascending aortaUBERON:000149666.20gold quality
transverse colonUBERON:000115765.86gold quality
lower esophagus muscularis layerUBERON:003583364.67gold quality
skin of abdomenUBERON:000141664.52gold quality
cerebellar hemisphereUBERON:000224564.38gold quality
subcutaneous adipose tissueUBERON:000219064.08gold quality
right ovaryUBERON:000211863.56gold quality
muscle layer of sigmoid colonUBERON:003580562.43gold quality
substantia nigraUBERON:000203861.53gold quality
skin of legUBERON:000151161.46gold quality
tibial arteryUBERON:000761060.68gold quality
spleenUBERON:000210660.57gold quality
corpus callosumUBERON:000233656.14gold quality
thyroid glandUBERON:000204655.99gold quality
pituitary glandUBERON:000000755.44gold quality
right testisUBERON:000453437.29gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.34

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 10)

  • Data show that Let-7f blocks IL-23R expression through its complementary target sequence within 3’ untranslated region of target gene. (PMID:21508257)
  • miR-205 and let-7f are biomarkers for ovarian cancer and may be predictive of ovarian cancer prognosis. (PMID:24223734)
  • Study show that Let-7f is down-regulated in glioma tissue and cell lines; its enhanced expression suppresses glioma cells proliferation, migration, and invasion via direct targeting perisotin suggesting it as an important role in glioma pathogenesis. (PMID:25735962)
  • The combination of serum let-7b, 7d, and 7f levels during the proliferative phase may serve as a diagnostic marker for endometriosis. (PMID:25772772)
  • genetic association study in population in Beijing, China: Data suggest SNPs in mirnlet7 (rs10993081 mirnlet7d, rs10877887 mirnlet7i, rs17276588 mirnlet7f) on chromosomes 9, 12, x are associated with metabolic syndrome in population studied. (PMID:26178671)
  • let-7f-5p functions as a potential inhibitor of Th17 differentiation in the pathogenesis of multiple sclerosis by targeting STAT3 (PMID:31326963)
  • Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line. (PMID:31793054)
  • Hypoxia-induced let-7f-5p/TARBP2 feedback loop regulates osteosarcoma cell proliferation and invasion by inhibiting the Wnt signaling pathway. (PMID:32305960)
  • Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. (PMID:35082326)
  • Genetic polymorphisms of pri-let-7f, gene-environment and gene-gene interactions, and associations with ischemic stroke risk in Liaoning Province. (PMID:37170751)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomirlet7g-1ENSDARG00000083280
danio_reriomirlet7g-2ENSDARG00000083425
mus_musculusMirlet7f-2ENSMUSG00000065602
rattus_norvegicusMirlet7f2ENSRNOG00000035464

Paralogs (10): MIRLET7E (ENSG00000198972), MIRLET7A2 (ENSG00000198975), MIRLET7C (ENSG00000199030), MIRLET7F1 (ENSG00000199072), MIRLET7D (ENSG00000199133), MIRLET7G (ENSG00000199150), MIRLET7A1 (ENSG00000199165), MIRLET7I (ENSG00000199179), MIR98 (ENSG00000271886), MIRLET7A3 (ENSG00000283990)

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.